Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
Chun Shing KwokChris P GaleTim KinnairdNick CurzenPeter F LudmanEvangelos KontopantelisJianhua WuTom DenwoodNadeem FazalJohn DeanfieldMark A de BelderMamas MamasPublished in: Heart (British Cardiac Society) (2020)
Following the lockdown in England, we observed a decline in primary PCI procedures for STEMI and increases in overall symptom-to-hospital and door-to-balloon time for patients with STEMI. Restructuring health services during COVID-19 has not adversely influenced in-hospital outcomes.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass grafting
- coronavirus disease
- healthcare
- sars cov
- acute care
- coronary artery bypass
- adverse drug
- atrial fibrillation
- weight loss
- skeletal muscle
- left ventricular
- patient reported
- emergency department
- respiratory syndrome coronavirus
- insulin resistance